Literature DB >> 33394329

Comparison of Alzheimer's disease patients and healthy controls in the easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: verification using normal database of our institution.

Makoto Ohba1, Ryota Kobayashi2, Kazukuni Kirii3, Kyosuke Fujita4, Chika Kanezawa4, Hiroshi Hayashi2, Shinobu Kawakatsu5, Koichi Otani2, Masafumi Kanoto3, Koji Suzuki4.   

Abstract

OBJECTIVE: The easy Z-score imaging system (eZIS) analysis is used for the diagnosis of dementia by cerebral blood flow on single photon emission computed tomography (SPECT). Differences in the acquisition and reconstruction conditions in SPECT may affect the eZIS analysis results. The present study aimed to construct our institutional normal database (NDB) and Alzheimer's disease (AD)-specific volumes of interest (VOIs) in eZIS analysis, and to compare the differential diagnostic ability between healthy controls (HC) and patients with AD in the image reconstruction filtered back projection (FBP) and ordered subset expectation maximization (OSEM) methods.
METHODS: An NDB was constructed at our institution from 30 healthy individual using the FBP and OSEM reconstruction methods. We divided 51 HC and 51 AD patients into two groups, one for AD disease-specific VOI construction (HC, AD) and the other for NDB verification (HC, AD); image reconstruction was performed using FBP and OSEM. The areas of reduced blood flow in AD patients were compared with those of HC using the two types of image reconstruction methods. We used AD disease-specific VOI and NDB from each reconstruction method in eZIS analysis and compared the differential diagnostic ability for HC and AD with the different reconstruction methods.
RESULTS: Comparing the areas of reduced blood flow in AD patients using the different image reconstruction methods, OSEM showed decreased blood flow in the medial region of the temporal lobes compared to FBP. Comparing the differential diagnostic ability for HC and AD using eZIS, the Severity, Extent, and Ratio showed higher values in the analysis performed using OSEM image reconstruction compared to FBP.
CONCLUSION: With the 99mTc-ECD SPECT, the eZIS analysis equipped with our institutional AD-specific VOI and NDB using OSEM image reconstruction could distinguish HC from AD better than eZIS analysis using FBP image reconstruction. This study is registered in UMIN Clinical Trials Registry (UMIN-CTR) as UMIN study ID: UMIN000042362.

Entities:  

Keywords:  Alzheimer’s disease; Cerebral blood flow; Easy Z-score imaging system; Ordered subset expectation maximization method; Single photon emission computed tomography

Year:  2021        PMID: 33394329     DOI: 10.1007/s12149-020-01562-8

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  4 in total

Review 1.  Technical overview of brain SPECT imaging: improving acquisition and processing of data.

Authors:  Gina N Morano; John P Seibyl
Journal:  J Nucl Med Technol       Date:  2003-12

2.  Comparison of methods of attenuation and scatter correction in brain perfusion SPECT.

Authors:  Masuo Hayashi; Jun Deguchi; Keita Utsunomiya; Makoto Yamada; Tsuyoshi Komori; Masayasu Takeuchi; Kensei Kanna; Isamu Narabayashi
Journal:  J Nucl Med Technol       Date:  2005-12

3.  Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.

Authors:  Etsuko Imabayashi; Hiroshi Matsuda; Takashi Asada; Takashi Ohnishi; Shigeki Sakamoto; Seigo Nakano; Tomio Inoue
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

4.  Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography.

Authors:  H Matsuda; S Mizumura; T Nagao; T Ota; T Iizuka; K Nemoto; N Takemura; H Arai; A Homma
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.